BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37628933)

  • 21. Transient hepatic attenuation differences (THAD) not connected to focal lesions.
    Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N
    Radiol Med; 2002; 104(1-2):25-43. PubMed ID: 12386553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).
    Wanless IR; Liu JJ; Butany J
    Hepatology; 1995 May; 21(5):1232-7. PubMed ID: 7737628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-cirrhotic portal hypertension].
    Kreisel W; Walter E; Gerok W
    Z Gastroenterol; 1990 Oct; 28(10):578-83. PubMed ID: 2275255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular liver disorders (II): portal vein thrombosis.
    Hoekstra J; Janssen HL
    Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-cirrhotic portal hypertension - The point of view of the pathologis].
    Blank A; Terracciano L
    Ther Umsch; 2019; 76(7):359-363. PubMed ID: 31913095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.
    Amitrano L; Guardascione MA; Ames PR
    Clin Lab; 2007; 53(9-12):583-9. PubMed ID: 18257465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sonographic diagnosis of hepatic vascular disorders.
    Zwiebel WJ
    Semin Ultrasound CT MR; 1995 Feb; 16(1):34-48. PubMed ID: 7718281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budd-Chiari Syndrome in a patient with Multiple Hypercoagulopathies.
    Kraleti S
    J Ark Med Soc; 2015 Oct; 112(6):90-1. PubMed ID: 26552285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.
    Tanaka M; Wanless IR
    Hepatology; 1998 Feb; 27(2):488-96. PubMed ID: 9462648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.
    Boyer-Diaz Z; Aristu-Zabalza P; Andrés-Rozas M; Robert C; Ortega-Ribera M; Fernández-Iglesias A; Broqua P; Junien JL; Wettstein G; Bosch J; Gracia-Sancho J
    J Hepatol; 2021 May; 74(5):1188-1199. PubMed ID: 33278455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic non-cirrhotic portal hypertension: a review.
    Schouten JN; Verheij J; Seijo S
    Orphanet J Rare Dis; 2015 May; 10():67. PubMed ID: 26025214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy and vascular liver disease.
    Bissonnette J; Durand F; de Raucourt E; Ceccaldi PF; Plessier A; Valla D; Rautou PE
    J Clin Exp Hepatol; 2015 Mar; 5(1):41-50. PubMed ID: 25941432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular liver diseases].
    Condat B
    Rev Prat; 2015 Jun; 65(6):754-6. PubMed ID: 26298892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.
    Valla DC; Cazals-Hatem D
    Virchows Arch; 2018 Jul; 473(1):3-13. PubMed ID: 29572606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-cirrhotic portal hypertension.
    Sarin SK; Khanna R
    Clin Liver Dis; 2014 May; 18(2):451-76. PubMed ID: 24679506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Porto-Sinusoidal Vascular Disease.
    Silva L; Moura R; Rocha L; Costa T; Breda F; Cochicho J
    Eur J Case Rep Intern Med; 2023; 10(12):004138. PubMed ID: 38077713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic portal hypertension and extrahepatic portal venous obstruction.
    Khanna R; Sarin SK
    Hepatol Int; 2018 Feb; 12(Suppl 1):148-167. PubMed ID: 29464506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-cirrhotic portal hypertension--concept, diagnosis and clinical management.
    Strauss E; Valla D
    Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):564-9. PubMed ID: 24581591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis.
    Rush N; Sun H; Nakanishi Y; Mneimneh W; Kwo PY; Saxena R
    Mod Pathol; 2016 May; 29(5):489-99. PubMed ID: 26916069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow's Triad.
    Anton A; Campreciós G; Pérez-Campuzano V; Orts L; García-Pagán JC; Hernández-Gea V
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.